Protein having activity as an angiogenesis modulator

Details Protein having activity as an angiogenesis modulator Protein having activity as an angiogenesis modulator

C - Chemistry, Metallurgy

12

N

C12N 15/12 (2006.01) A61K 38/17 (2006.01) A61K 48/00 (2006.01) C07K 14/78 (2006.01) C07K 16/18 (2006.01) G01N 33/68 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2388673

BTL.012 is a novel human protein useful for regulating or modulating angiogenesis. BTL.012, or variants thereof, may be employed as therapeutics in diseases such as cancer, wound healing, diabetic retinopathies, macular degeneration, and cardiovascular diseases, and other diseases or clinical conditions where angiogenesis is relevant to the causation or treatment of the disease.

BTL.012 est une nouvelle protéine humaine pouvant réguler ou moduler l'angiogenèse. BTL.012 ou des variantes de cette protéine peuvent être utilisées à des fins thérapeutiques contre des maladies, telles que le cancer, les blessures, les rétinopathies diabétiques, la dégénérescence maculaire, ou les maladies cardiovasculaires et autres maladies ou pathologies cliniques dans lesquelles l'angiogenèse est une des causes à l'origine de la maladie ou intervient dans le traitement de la maladie.

Affiliated with

Also associated with

Rating

Protein having activity as an angiogenesis modulator does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protein having activity as an angiogenesis modulator, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein having activity as an angiogenesis modulator will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1383482